New drug combo aims to boost survival in advanced lung cancer
Disease control
Completed
This phase 3 trial tested whether adding plinabulin to the chemotherapy drug docetaxel helps people with advanced non-small cell lung cancer live longer. 559 participants who had already tried one or two prior treatments received either the combination or docetaxel alone. The stu…
Phase: PHASE3 • Sponsor: BeyondSpring Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC